ROLE OF NEUROLEPTICS IN EFFECTIVE TREATMENT OF PARANOID SCHIZOPHRENIA
According to statistics, the incidence of paranoid schizophrenia is about 1% of the total population. The debut, or the first bright episode of the manifestation of the disease occurs at the age of 30 years. It is important to understand that accompanying symptoms and signs can be observed for a long time before the first attack, but they must be recognized and classified in a timely manner. Schizophrenia itself appears without any external reason - it is believed that a hereditary factor plays an important role in this case. Paranoid schizophrenia has a significant impact on the daily functioning, communication with others, personal life and working condition of the patient.